Development of the implantable transvenous cardioverter

Douglas P. Zipes, James J. Heger, William M. Miles, Eric N. Prystowsky

Research output: Contribution to journalArticle

Abstract

The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

Original languageEnglish
JournalThe American Journal of Cardiology
Volume54
Issue number9
DOIs
StatePublished - 1984

Fingerprint

Ventricular Tachycardia
Heart Ventricles
Cardiac Arrhythmias
Shock
Electrodes
Catheters
Equipment and Supplies
Clinical Studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Development of the implantable transvenous cardioverter. / Zipes, Douglas P.; Heger, James J.; Miles, William M.; Prystowsky, Eric N.

In: The American Journal of Cardiology, Vol. 54, No. 9, 1984.

Research output: Contribution to journalArticle

Zipes, Douglas P. ; Heger, James J. ; Miles, William M. ; Prystowsky, Eric N. / Development of the implantable transvenous cardioverter. In: The American Journal of Cardiology. 1984 ; Vol. 54, No. 9.
@article{ba29fff39b0543b5850a00ae30705364,
title = "Development of the implantable transvenous cardioverter",
abstract = "The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.",
author = "Zipes, {Douglas P.} and Heger, {James J.} and Miles, {William M.} and Prystowsky, {Eric N.}",
year = "1984",
doi = "10.1016/S0002-9149(84)80289-1",
language = "English",
volume = "54",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Development of the implantable transvenous cardioverter

AU - Zipes, Douglas P.

AU - Heger, James J.

AU - Miles, William M.

AU - Prystowsky, Eric N.

PY - 1984

Y1 - 1984

N2 - The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

AB - The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

UR - http://www.scopus.com/inward/record.url?scp=0021718041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021718041&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(84)80289-1

DO - 10.1016/S0002-9149(84)80289-1

M3 - Article

C2 - 6496370

AN - SCOPUS:0021718041

VL - 54

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -